Confluence Investment Management LLC Decreases Stock Holdings in The Clorox Company $CLX

Confluence Investment Management LLC lessened its stake in shares of The Clorox Company (NYSE:CLX) by 1.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 931,093 shares of the company’s stock after selling 10,417 shares during the quarter. Clorox comprises about 1.6% of Confluence Investment Management LLC’s investment portfolio, making the stock its 23rd biggest holding. Confluence Investment Management LLC owned 0.76% of Clorox worth $114,804,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in the stock. Nomura Asset Management Co. Ltd. lifted its stake in shares of Clorox by 9.0% during the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 335,514 shares of the company’s stock valued at $40,285,000 after buying an additional 27,639 shares in the last quarter. Simplicity Wealth LLC raised its holdings in Clorox by 157.3% during the second quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock valued at $2,199,000 after acquiring an additional 11,198 shares during the period. Hudson Bay Capital Management LP purchased a new position in shares of Clorox in the second quarter valued at about $8,568,000. Vise Technologies Inc. bought a new position in shares of Clorox in the second quarter worth about $328,000. Finally, Amundi grew its position in shares of Clorox by 1.1% during the second quarter. Amundi now owns 940,399 shares of the company’s stock worth $117,230,000 after purchasing an additional 10,108 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Wells Fargo & Company lowered their price target on Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. The Goldman Sachs Group dropped their target price on shares of Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research report on Wednesday, October 1st. Citigroup reduced their price target on shares of Clorox from $120.00 to $109.00 and set a “neutral” rating on the stock in a report on Wednesday, December 17th. Bank of America dropped their price objective on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. One equities research analyst has rated the stock with a Buy rating, thirteen have issued a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and an average price target of $125.00.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber acquired 4,000 shares of the company’s stock in a transaction on Friday, November 21st. The stock was bought at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the purchase, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. This represents a 44.44% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.63% of the stock is currently owned by corporate insiders.

Clorox Stock Performance

Clorox stock opened at $98.04 on Tuesday. The company’s 50-day moving average price is $107.47 and its 200-day moving average price is $117.86. The company has a quick ratio of 0.50, a current ratio of 0.76 and a debt-to-equity ratio of 18.01. The company has a market cap of $11.96 billion, a PE ratio of 15.39, a price-to-earnings-growth ratio of 0.49 and a beta of 0.57. The Clorox Company has a twelve month low of $97.39 and a twelve month high of $164.41.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same quarter last year, the business posted $1.86 earnings per share. The firm’s revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be issued a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 5.1%. The ex-dividend date is Wednesday, January 28th. Clorox’s dividend payout ratio is presently 77.86%.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.